- doi:10.1007/s10689-007-9165-5. PMID 17999161. S2CID 20103607. Lynch, H. T.;
Lanspa, S. J. (2010). "Colorectal
Cancer Survival Advantage in MUTYH-****ociated...
- doi:10.1007/s10689-007-9165-5. PMID 17999161. S2CID 20103607.
Lynch HT,
Lanspa SJ (November 2010). "Colorectal
cancer survival advantage in MUTYH-****ociated...
- 036350. PMC 1774264. PMID 15479672.
Sontineni SP,
Chaudhary S,
Sontineni V,
Lanspa SJ (March 2009). "Cannabinoid
hyperemesis syndrome:
clinical diagnosis of...
- Laryngoscope. 127 (8): S1–S10. doi:10.1002/lary.26854. PMC 5788193. PMID 28884823.
Lanspa M,
Peyrani P,
Wiemkwn T,
Wilson E,
Ramirez J, Dean N (2015). "Characteristics...
-
Administration (FDA) (Report).
January 2018.
Retrieved 16
September 2020.
Brown SM,
Lanspa MJ,
Jones JP,
Kuttler KG, Li Y,
Carlson R, et al. (March 2013). "Survival...
- PMID 32805203. Callahan, SJ; Harris, D; Collingridge, DS; Guidry, DW; Dean, NC;
Lanspa, MJ; Blagev, DP (November 2020). "Diagnosing
EVALI in the Time of COVID-19"...
- O; Eve,
Jacqueline R.; Waddoups, Lindsey; Aston, Valerie; Brown, Samuel;
Lanspa,
Michael J (9 May 2022). "Prospectively ****essed Long-Term
Outcomes of Patients...
- 1007/s10911-011-9200-x. PMID 21360002. S2CID 21417924.
Lynch HT,
Lynch PM,
Lanspa SJ,
Snyder CL,
Lynch JF,
Boland CR (July 2009). "Review of the
Lynch syndrome:...
